相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma
Johanna Grund et al.
BRITISH JOURNAL OF HAEMATOLOGY (2023)
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
Johanna Bendell et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation
Yun-Shan Lin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Estrogen downregulates CD73/adenosine axis hyperactivity via adaptive modulation PI3K/Akt signaling to prevent myocarditis and arrhythmias during chronic catecholamines stress
Marie Louise Ndzie Noah et al.
CELL COMMUNICATION AND SIGNALING (2023)
Aberrant adenosine signaling in patients with focal cortical dysplasia
Mengyi Guo et al.
MOLECULAR NEUROBIOLOGY (2023)
Prognostic impact of CD73/adenosine 2A receptor (A2AR) in renal cell carcinoma and immune microenvironmental status with sarcomatoid changes and rhabdoid features
Dai Takamatsu et al.
PATHOLOGY RESEARCH AND PRACTICE (2023)
Abnormal adenosine metabolism of neutrophils inhibits airway inflammation and remodeling in asthma model induced by Aspergillus fumigatus
Ting-ting Liu et al.
BMC PULMONARY MEDICINE (2023)
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types
Razvan Cristescu et al.
CLINICAL CANCER RESEARCH (2022)
Tumor Infiltration with CD20+CD73+ B Cells Correlates with Better Outcome in Colorectal Cancer
Frederik J. Hansen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer
Richard A. Miller et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
Kun Tang et al.
CANCERS (2022)
Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts
Jiefu Zhou et al.
FRONTIERS IN ONCOLOGY (2022)
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
Ryohei Yoshida et al.
CANCER RESEARCH (2022)
Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts
Zixu Gao et al.
FRONTIERS IN IMMUNOLOGY (2022)
Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment
Xin-miao Xue et al.
FRONTIERS IN PHARMACOLOGY (2022)
Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B
Shuang-Nan Zhou et al.
GASTROENTEROLOGY REPORT (2021)
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
Pedro Rocha et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer
Katherine C. Kurnit et al.
CANCER LETTERS (2021)
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
Lorna B. Jarvis et al.
COMMUNICATIONS BIOLOGY (2021)
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
Nataliia Petruk et al.
SCIENTIFIC REPORTS (2021)
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Paris Jabeen Asif et al.
CANCERS (2021)
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
Shi Yong Neo et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
Miao Yu et al.
NATURE COMMUNICATIONS (2020)
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation
Willem van de Veen et al.
SCIENCE ADVANCES (2020)
EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinoma
Limei Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Targeting CD73 to augment cancer immunotherapy
Meejeon Roh et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
CD8+CD73+T cells in the tumor microenvironment of head and neck cancer patients are linked to diminished T cell infiltration and activation in tumor tissue
Soumya Panigrahi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Memory CD73+IgM+B cells protect againstPlasmodium yoelii infection and express Granzyme B
Marcela Parra et al.
PLOS ONE (2020)
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma
Abhishek Tripathi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL
M. Kicova et al.
NEOPLASMA (2020)
Downregulation of CD73 associates with T cell exhaustion in AML patients
Yaxian Kong et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
Ivan Perrot et al.
CELL REPORTS (2019)
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis
Bertrand Allard et al.
ONCOIMMUNOLOGY (2019)
Cell type- and tissue-specific functions of ecto-5′-nucleotidase (CD73)
Marquet Minor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
CD73: an emerging checkpoint for cancer immunotherapy
Siqi Chen et al.
IMMUNOTHERAPY (2019)
Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer
Maarit K. Koivisto et al.
CARCINOGENESIS (2019)
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Detlev Boison et al.
CANCER CELL (2019)
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome
Xianhuo Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl et al.
JCI INSIGHT (2019)
Autocrine Adenosine Regulates Tumor Polyfunctional CD73(+)CD4(+) Effector T Cells Devoid of Immune Checkpoints
Nicolas Gourdin et al.
CANCER RESEARCH (2018)
MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer
Maria Saigi et al.
CLINICAL CANCER RESEARCH (2018)
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models
Stephen B. Willingham et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
L. Buisseret et al.
ANNALS OF ONCOLOGY (2018)
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells
Fernando P. Canale et al.
CANCER RESEARCH (2018)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure
Eunyoung Tak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
Samaneh Arab et al.
TUMOR BIOLOGY (2017)
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF--mTOR-HIF-1 signaling in patients with non-small cell lung cancer
Jieyao Li et al.
ONCOIMMUNOLOGY (2017)
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Bruno G. Leclerc et al.
CLINICAL CANCER RESEARCH (2016)
Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
Jessica L. Bowser et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
Deepak Mittal et al.
CANCER RESEARCH (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
TGF-beta in tolerance, development and regulation of immunity
Chris J. C. Johnston et al.
CELLULAR IMMUNOLOGY (2016)
Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF
Tsuguhide Takeshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Purinergic Signaling to Terminate TLR Responses in Macrophages
Kajal Hamidzadeh et al.
FRONTIERS IN IMMUNOLOGY (2016)
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
Itsaso Montalban del Barrio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
Luca Antonioli et al.
TRENDS IN CANCER (2016)
A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance
Elodie Robin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2015)
Releasing the Brakes on Cancer Immunotherapy
Antoni Ribas
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
Fabio Morandi et al.
ONCOTARGET (2015)
Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
Shilpak Chatterjee et al.
CANCER RESEARCH (2014)
Anti-CD73 therapy impairs tumor angiogenesis
Bertrand Allard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Adenosine-a physiological or pathophysiological agent?
Bertil B. Fredholm
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A2A receptor levels in rats subjected to neuroinflammation
Mark D. Smith et al.
JOURNAL OF NEUROINFLAMMATION (2014)
CD73 Expression Is Dynamically Regulated in the Germinal Center and Bone Marrow Plasma Cells Are Diminished in Its Absence
Laura J. Conter et al.
PLOS ONE (2014)
The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study
Geoff Bellingan et al.
LANCET RESPIRATORY MEDICINE (2014)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages
Balazs Koscso et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Regulation of Neutrophil Function by Adenosine
Kathryn E. Barletta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
CD73-Deficient Mice Are Resistant to Carcinogenesis
John Stagg et al.
CANCER RESEARCH (2012)
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Fanny Chalmin et al.
IMMUNITY (2012)
Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory
Tomohiro Kaji et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
A germinal center-independent pathway generates unswitched memory B cells early in the primary response
Justin J. Taylor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
Rafael Fernandes Zanin et al.
PLOS ONE (2012)
Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
Karen Knapp et al.
STRUCTURE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Immune cell regulation by autocrine purinergic signalling
Wolfgang G. Junger
NATURE REVIEWS IMMUNOLOGY (2011)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Endothelial-Specific Deletion of Connexin40 Promotes Atherosclerosis by Increasing CD73-Dependent Leukocyte Adhesion
C. E. Chadjichristos et al.
CIRCULATION (2010)
Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1
Carina Strell et al.
EXPERIMENTAL CELL RESEARCH (2010)
Cancer associated fibroblasts (CAFs) in tumor microenvironment
Fei Xing et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
CD73 represses pro-inflammatory responses in human endothelial cells
Jana K. G. Gruenewald et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Magis Mandapathil et al.
CLINICAL CANCER RESEARCH (2009)
Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs
Joerg Reutershan et al.
FASEB JOURNAL (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation
Sirpa Jalkanen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes
Masahide Takedachi et al.
JOURNAL OF IMMUNOLOGY (2008)
A(2A) receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Paul E. Zarek et al.
BLOOD (2008)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Coffee, cirrhosis, and transaminase enzymes
Arthur L. Klatsky et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors
S Minguet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism
HK Eltzschig et al.
BLOOD (2004)
Crucial role for ecto-5-′nucleotidase (CD73) in vascular leakage during hypoxia
LF Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response
P Koszalka et al.
CIRCULATION RESEARCH (2004)
Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by ecto-5′-nucleotidase/CD73-dependent mechanism
T Henttinen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ecto 5′-nucleotidase and nonspecific alkaline phosphatase -: Two amp-hydrolyzing ectoenzymes with distinct roles in human airways
M Picher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8
H Schaider et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The roles of IFNγ in protection against tumor development and cancer immunoediting
H Ikeda et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Regulation of ecto-5 '-nucleotidase by TNF-alpha in human endothelial cells
K Kalsi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
分享论文
